Knockdown of HMGA1 inhibits human breast cancer cell growth and metastasis in immunodeficient mice

Biochemical and Biophysical Research Communications

Volumn 434, Issue 1, 2013, Pages 70-74

  Di Cello, Francescopaolo ^a   Shin, James ^a   Harbom, Kirsten ^a   Brayton, Cory ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; HMGA1; Knockdown; Metastasis; Xenograft

Indexed keywords

HIGH MOBILITY GROUP A1A PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG METASTASIS; LYMPH NODE METASTASIS; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HMGA1A PROTEIN; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; SPHEROIDS, CELLULAR; TRANSPLANTATION, HETEROLOGOUS;

MUS;

EID: 84876791359     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.03.064     Document Type: Article

References (28)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, D.M. Parkin, GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [internet], International Agency for Research on Cancer, Lyon, France, 2010. Available from: accessed on 16 March 2013. http://globocan.iarc.fr.
2. American Cancer Society, Cancer Facts & Figures 2013, American Cancer Society, Atlanta, 2013.
3. Ferlay J., Steliarova-Foucher E., Lortet-Tieulent J., Rosso S., Coebergh J.W.W., Comber H., Forman D., Bray F. Cancer incidence and mortality patterns in europe: estimates for 40 countries in 2012. Eur. J. Cancer 2013.
4. Peluso S., Chiappetta G. High-mobility group A (HMGA) proteins and breast cancer. Breast Care (Basel) 2010, 5:81-85.
5. Reeves R., Beckerbauer L. HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim. Biophys. Acta 2001, 1519:13-29.
6. Fedele M., Fusco A. HMGA and cancer. Biochim. Biophys. Acta 2010, 1799:48-54.
7. Resar L.M. The high mobility group A1 gene: transforming inflammatory signals into cancer?. Cancer Res. 2010, 70:436-439.
8. Fusco A., Fedele M. Roles of HMGA proteins in cancer. Nat. Rev. Cancer 2007, 7:899-910.
9. Xu Y., Sumter T.F., Bhattacharya R., Tesfaye A., Fuchs E.J., Wood L.J., Huso D.L., Resar L.M. The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia. Cancer Res. 2004, 64:3371-3375.
10. Abe N., Watanabe T., Masaki T., Mori T., Sugiyama M., Uchimura H., Fujioka Y., Chiappetta G., Fusco A., Atomi Y. Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins. Cancer Res. 2000, 60:3117-3122.
11. Hristov A.C., Cope L., Di Cello F., Reyes M.D., Singh M., Hillion J.A., Belton A., Joseph B., Schuldenfrei A., Iacobuzio-Donahue C.A., Maitra A., Resar L.M. HMGA1 correlates with advanced tumor grade and decreased survival in pancreatic ductal adenocarcinoma. Mod. Pathol. 2010, 23:98-104.
12. Chiappetta G., Tallini G., De Biasio M.C., Manfioletti G., Martinez-Tello F.J., Pentimalli F., de Nigris F., Mastro A., Botti G., Fedele M., Berger N., Santoro M., Giancotti V., Fusco A. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Cancer Res. 1998, 58:4193-4198.
13. Chiappetta G., Manfioletti G., Pentimalli F., Abe N., Di Bonito M., Vento M.T., Giuliano A., Fedele M., Viglietto G., Santoro M., Watanabe T., Giancotti V., Fusco A. High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases. Int. J. Cancer 2001, 91:147-151.
14. Dolde C.E., Mukherjee M., Cho C., Resar L.M. HMG-I/Y in human breast cancer cell lines. Breast Cancer Res. Treat. 2002, 71:181-191.
15. Chiappetta G., Botti G., Monaco M., Pasquinelli R., Pentimalli F., Di Bonito M., D'Aiuto G., Fedele M., Iuliano R., Palmieri E.A., Pierantoni G.M., Giancotti V., Fusco A. HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression. Clin. Cancer Res. 2004, 10:7637-7644.
16. Flohr A.M., Rogalla P., Bonk U., Puettmann B., Buerger H., Gohla G., Packeisen J., Wosniok W., Loeschke S., Bullerdiek J. High mobility group protein HMGA1 expression in breast cancer reveals a positive correlation with tumour grade. Histol. Histopathol. 2003, 18:999-1004.
17. Hillion J., Wood L.J., Mukherjee M., Bhattacharya R., Di Cello F., Kowalski J., Elbahloul O., Segal J., Poirier J., Rudin C.M., Dhara S., Belton A., Joseph B., Zucker S., Resar L.M. Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancer. Mol. Cancer Res. 2009, 7:1803-1812.
18. Masciullo V., Baldassarre G., Pentimalli F., Berlingieri M.T., Boccia A., Chiappetta G., Palazzo J., Manfioletti G., Giancotti V., Viglietto G., Scambia G., Fusco A. HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas. Carcinog. 2003, 24:1191-1198.
19. Tesfaye A., Di Cello F., Hillion J., Ronnett B.M., Elbahloul O., Ashfaq R., Dhara S., Prochownik E., Tworkoski K., Reeves R., Roden R., Ellenson L.H., Huso D.L., Resar L.M. The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis. Cancer Res. 2007, 67:3998-4004.
20. Tamimi Y., van der Poel H.G., Denyn M.M., Umbas R., Karthaus H.F., Debruyne F.M., Schalken J.A. Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization. Cancer Res. 1993, 53:5512-5516.
21. Rho Y.S., Lim Y.C., Park I.S., Kim J.H., Ahn H.Y., Cho S.J., Shin H.S. High mobility group HMGI(Y) protein expression in head and neck squamous cell carcinoma. Acta Otolaryngol. 2007, 127:76-81.
22. Reeves R., Edberg D.D., Li Y. Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol. Cell Biol. 2001, 21:575-594.
23. Liu W.M., Guerra-Vladusic F.K., Kurakata S., Lupu R., Kohwi-Shigematsu T. HMG-I(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype. Cancer Res. 1999, 59:5695-5703.
24. Guadamillas M.C., Cerezo A., Del Pozo M.A. Overcoming anoikis-pathways to anchorage-independent growth in cancer. J. Cell Sci. 2011, 124:3189-3197.
25. Dontu G., Abdallah W.M., Foley J.M., Jackson K.W., Clarke M.F., Kawamura M.J., Wicha M.S. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003, 17:1253-1270.
26. Ponti D., Costa A., Zaffaroni N., Pratesi G., Petrangolini G., Coradini D., Pilotti S., Pierotti M.A., Daidone M.G. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 2005, 65:5506-5511.
27. Evans A., Lennard T.W., Davies B.R. High-mobility group protein 1(Y): metastasis-associated or metastasis-inducing?. J. Surg. Oncol. 2004, 88:86-99.
28. Schuldenfrei A., Belton A., Kowalski J., Talbot C.C., Di Cello F., Poh W., Tsai H.L., Shah S.N., Huso T.H., Huso D.L., Resar L.M. HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis. BMC Genomics 2011, 12:549.